Filing Details
- Accession Number:
- 0001209191-23-030167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-17 16:21:18
- Reporting Period:
- 2023-05-15
- Accepted Time:
- 2023-05-17 16:21:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1688712 | Carter Dawn Bir | 5320 Legacy Dr. Plano TX 75024 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-05-15 | 894 | $85.09 | 31,302 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-16 | 417 | $80.96 | 30,885 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.